Nuveen Asset Management, LLC Axogen, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 148,446 shares of AXGN stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

148,446

Previous 353,136 57.96%

Holding current value

$2.15 Million

Previous $2.56 Million 18.58%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.52 - $14.69 $1.54 Million - $3.01 Million	-204,690 Reduced 57.96%	148,446 $2.08 Million
Q4 2023 Feb 14, 2024	BUY	$3.61 - $7.76 $596,769 - $1.28 Million	165,310 Added 88.01%	353,136 $2.41 Million
Q3 2023 Nov 14, 2023	BUY	$4.68 - $9.26 $11,620 - $22,992	2,483 Added 1.34%	187,826 $939,000
Q2 2023 Aug 14, 2023	BUY	$8.5 - $10.38 $29,656 - $36,215	3,489 Added 1.92%	185,343 $1.69 Million
Q1 2023 May 15, 2023	BUY	$7.53 - $10.95 $59,976 - $87,216	7,965 Added 4.58%	181,854 $1.72 Million
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $613,250 - $850,365	64,963 Added 59.64%	173,889 $1.74 Million
Q3 2022 Nov 14, 2022	SELL	$8.14 - $12.25 $72,502 - $109,110	-8,907 Reduced 7.56%	108,926 $1.3 Million
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $302,401 - $432,620	-43,262 Reduced 26.85%	117,833 $965,000
Q1 2022 May 16, 2022	BUY	$7.26 - $10.7 $56,410 - $83,139	7,770 Added 5.07%	161,095 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$8.8 - $16.0 $66,994 - $121,808	-7,613 Reduced 4.73%	153,325 $1.44 Million
Q3 2021 Nov 12, 2021	SELL	$15.23 - $21.72 $798,036 - $1.14 Million	-52,399 Reduced 24.56%	160,938 $2.54 Million
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $1.13 Million - $1.49 Million	63,494 Added 42.37%	213,337 $4.61 Million
Q1 2021 May 17, 2021	BUY	$17.18 - $22.6 $89,902 - $118,265	5,233 Added 3.62%	149,843 $3.04 Million
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $5,359 - $8,369	466 Added 0.32%	144,610 $2.59 Million
Q3 2020 Nov 16, 2020	BUY	$10.62 - $13.12 $47,662 - $58,882	4,488 Added 3.21%	144,144 $1.68 Million
Q2 2020 Aug 14, 2020	SELL	$7.35 - $10.81 $110,367 - $162,322	-15,016 Reduced 9.71%	139,656 $1.29 Million
Q1 2020 May 14, 2020	SELL	$8.38 - $17.34 $2,991 - $6,190	-357 Reduced 0.23%	154,672 $1.61 Million
Q4 2019 Feb 14, 2020	SELL	$11.18 - $18.6 $55,743 - $92,739	-4,986 Reduced 3.12%	155,029 $2.77 Million
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $33,694 - $57,022	2,787 Added 1.77%	160,015 $2 Million
Q2 2019 Aug 15, 2019	BUY	$18.5 - $25.47 $2.91 Million - $4 Million	157,228 New	157,228 $3.11 Million

Others Institutions Holding AXGN

# of Institutions

163

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $612M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Axogen, Inc. Transaction History